These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML Retina; 2007; 27(4):439-44. PubMed ID: 17420695 [TBL] [Abstract][Full Text] [Related]
8. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A Retina; 2006; 26(9):988-93. PubMed ID: 17151484 [TBL] [Abstract][Full Text] [Related]
9. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Algvere PV; Steén B; Seregard S; Kvanta A Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238 [TBL] [Abstract][Full Text] [Related]
11. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Lazic R; Gabric N Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):68-73. PubMed ID: 17111146 [TBL] [Abstract][Full Text] [Related]
12. Treatment of choroidal neovascularization using intravitreal bevacizumab. Pedersen R; Soliman W; Lund-Andersen H; Larsen M Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757 [TBL] [Abstract][Full Text] [Related]
13. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G Retina; 2006; 26(5):495-511. PubMed ID: 16770255 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Bashshur ZF; Bazarbachi A; Schakal A; Haddad ZA; El Haibi CP; Noureddin BN Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study. Abrahám-Marin ML; Cortés-Luna CF; Alvarez-Rivera G; Hernández-Rojas M; Quiroz-Mercado H; Morales-Cantón V Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):651-5. PubMed ID: 17006681 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Bom Aggio F; Eid Farah M; Melo GB Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511 [No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764 [TBL] [Abstract][Full Text] [Related]
19. [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress]. Kook D; Wolf A; Neubauer AS; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW Ophthalmologe; 2008 Feb; 105(2):158-64. PubMed ID: 17653552 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration. Chen E; Kaiser RS; Vander JF Retina; 2007; 27(4):445-50. PubMed ID: 17420696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]